NUTM2A and cancer: In conclusion, while our current understanding of NUTM2A-AS1 as a key ceRNA in cancer has substantially advanced, ongoing and future studies are essential to fully elucidate its molecular mechanisms and to harness its potential in improving cancer diagnosis, prognosis, and treatment.